ADMA Biologics ADMA EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's EBIT?
- ADMA Biologics (ADMA) reported EBIT of $58.27M in Q1 2026.
- How has ADMA Biologics's EBIT changed year-over-year?
- ADMA Biologics's EBIT increased by 67.1% year-over-year, from $34.88M to $58.27M.
- What is the long-term trend for ADMA Biologics's EBIT?
- Over 4 years (2021 to 2025), ADMA Biologics's EBIT has grown at a 34.6% compound annual growth rate (CAGR), from -$58.37M to $191.44M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.